MedPath

Colistin infusio

Phase 4
Recruiting
Conditions
Kidney failure.
Acute kidney failure
Registration Number
IRCT20160713028901N5
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Age 18 to 50 years
Receiving colistin at a dose of 4.5 million units every 12 hours (or an equivalent dose according to the patient's kidney function)
Creatinine clearance above 50 ml/min at the beginning of the study
No history of acute kidney injury (based on history and medical history)
Failure to receive other nephrotoxic drugs such as aminoglycosides, amphotericin B, cyclosporine, tacrolimus, furosemide and NSAIDs
Not receiving other antioxidant supplements such as vitamins C and E

Exclusion Criteria

Recent use of colistin in the last 7 days
Using colistin for less than 3 days
Dialysis before starting treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum creatinine level (SCr). Timepoint: before starting the treatment, during the treatment for one day in between and also 12 hours after the last dose of colistin on the tenth day of treatment with this antibiotic (before receiving any other dose of colistin). Method of measurement: Hospital laboratory.;Blood urea nitrogen (BUN). Timepoint: before starting the treatment, during the treatment for one day in between and also 12 hours after the last dose of colistin on the tenth day of treatment with this antibiotic (before receiving any other dose of colistin). Method of measurement: Hospital laboratory.;Creatinine clearance (CrCl). Timepoint: before starting the treatment, during the treatment for one day in between and also 12 hours after the last dose of colistin on the tenth day of treatment with this antibiotic (before receiving any other dose of colistin). Method of measurement: calculating by equation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath